Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease
- PMID: 26097546
- PMCID: PMC4466933
Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease
Abstract
Intestinal mucosal barrier dysfunction is closely related to liver diseases, which implies impaired gut-liver axis may play a role in the pathogenesis of NAFLD. In our study, rats were divided into three groups: normal chow diet (NCD) group, high-fat diet (HFD) group and TNBS-induced colitis with high-fat diet (C-HFD) group. Liver tissues were obtained for histological observation and TNF-α, IL-6 mRNA determination and blood samples were collected for liver enzymes and LPS analysis. Ultrastructural changes of jejuna epithelium, SIBO and amounts of CD103(+)MHCII(+)DCs and CD4(+)CD25(+)FoxP3(+)T-regs in terms of percentage in mesenteric lymph nodes (MLN) were observed by electron microscope, bacterial cultivation and flow cytometry, respectively. The results demonstrated the pathological characteristics accorded with nonalcoholic simple fatty liver (NAFL) and NASH in HFD group by week 8 and 12, respectively. Besides, the degree of hepatic steatosis and steatohepatitis was more severe in C-HFD group compared with HFD-group at the same time point. NAFLD activity score (NAS), liver enzymes, concentration of LPS and mRNA expressions of TNF-α, IL-6 were higher significantly in C-HFD group compared with HFD and NCD group at week 4, 8 and 12, respectively. In HFD group, epithelium microvilli atrophy, disruptive tight junctions and SIBO were present, and these changes were more severe in NASH compared with NAFL. The percentage of CD103+MHCII+DCs and CD4+CD25+FoxP3+T-regs decreased significantly in NAFL and NASH compared with NCD group. Our conclusion was that gut-liver axis was impaired in NAFLD, which played crucial role in the pathogenesis of NAFLD.
Keywords: IL-6; Nonalcoholic fatty liver disease; TNF-α; dendritic cell; intestinal mucosal barrier; regulatory T cell.
Figures
Similar articles
-
Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.Life Sci. 2018 Sep 15;209:157-166. doi: 10.1016/j.lfs.2018.08.017. Epub 2018 Aug 7. Life Sci. 2018. PMID: 30096384
-
High fat diet exacerbates dextran sulfate sodium induced colitis through disturbing mucosal dendritic cell homeostasis.Int Immunopharmacol. 2016 Nov;40:1-10. doi: 10.1016/j.intimp.2016.08.018. Epub 2016 Aug 24. Int Immunopharmacol. 2016. PMID: 27567245
-
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.J Immunol. 2016 Jan 1;196(1):97-105. doi: 10.4049/jimmunol.1501175. Epub 2015 Nov 30. J Immunol. 2016. PMID: 26621860
-
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539. World J Gastroenterol. 2014. PMID: 25400438 Free PMC article. Review.
-
Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis.World J Gastroenterol. 2016 Nov 7;22(41):9096-9103. doi: 10.3748/wjg.v22.i41.9096. World J Gastroenterol. 2016. PMID: 27895397 Free PMC article. Review.
Cited by
-
Effect of Trichinella spiralis-Derived Antigens on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice.ACS Pharmacol Transl Sci. 2024 Jan 18;7(2):432-444. doi: 10.1021/acsptsci.3c00276. eCollection 2024 Feb 9. ACS Pharmacol Transl Sci. 2024. PMID: 38357280
-
Taurine Regulates the Expression of Interleukin -17/10 and Intestinal Flora and Protects the Liver and Intestinal Mucosa in a Nonalcoholic Fatty Liver Disease Rat Model.Diabetes Metab Syndr Obes. 2024 Feb 9;17:675-689. doi: 10.2147/DMSO.S440978. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38352234 Free PMC article.
-
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk.Nutrients. 2023 Sep 14;15(18):3970. doi: 10.3390/nu15183970. Nutrients. 2023. PMID: 37764755 Free PMC article. Review.
-
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023 Mar 2;10:1120168. doi: 10.3389/fnut.2023.1120168. eCollection 2023. Front Nutr. 2023. PMID: 36937361 Free PMC article. Review.
-
PTPN2 regulates bacterial clearance in a mouse model of enteropathogenic and enterohemorrhagic E. coli infection.JCI Insight. 2023 Feb 22;8(4):e156909. doi: 10.1172/jci.insight.156909. JCI Insight. 2023. PMID: 36810248 Free PMC article.
References
-
- Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 2009;116:539–564. - PubMed
-
- Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836–1846. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials